AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / MISCELLANEOUS BUSINESS CREDIT INSTITUTION
SWK Holdings Corporation 9.00% Senior Notes due 2027
XNAS · usd
SIC 6159 · MISCELLANEOUS BUSINESS CREDIT INSTITUTION
FIGI AK-1C7E4283BA
25.17▲ 0.03 (0.12%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
25.14
Day's Range
25.14 – 25.17
52-Week Range
24.34 – 25.92
Volume
4,230
Avg Volume
5,323
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2023-10-04
Share count as of March 16, 2026

SWK Holdings Corporation 9.00% Senior Notes due 2027 (SWKHL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about SWK Holdings Corporation 9.00% Senior Notes due 2027 (SWKHL)
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's Market Cap?
SWK Holdings Corporation 9.00% Senior Notes due 2027's Market Cap is $304.4M, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's Enterprise Value?
SWK Holdings Corporation 9.00% Senior Notes due 2027's Enterprise Value is $294.6M, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's Price / Sales?
SWK Holdings Corporation 9.00% Senior Notes due 2027's Price / Sales is 7.3×, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's EV / Revenue?
SWK Holdings Corporation 9.00% Senior Notes due 2027's EV / Revenue is 7.1×, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's EV / EBITDA?
SWK Holdings Corporation 9.00% Senior Notes due 2027's EV / EBITDA is 14.5×, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's Revenue (TTM)?
SWK Holdings Corporation 9.00% Senior Notes due 2027's Revenue (TTM) is $41.5M, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's Net Income (TTM)?
SWK Holdings Corporation 9.00% Senior Notes due 2027's Net Income (TTM) is -$2.5M, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's EBITDA?
SWK Holdings Corporation 9.00% Senior Notes due 2027's EBITDA is $20.3M, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's Diluted EPS (TTM)?
SWK Holdings Corporation 9.00% Senior Notes due 2027's Diluted EPS (TTM) is -0.21, based on as-reported figures from SEC (XBRL) filings.
What is SWK Holdings Corporation 9.00% Senior Notes due 2027's EBITDA Margin?
SWK Holdings Corporation 9.00% Senior Notes due 2027's EBITDA Margin is 49.0%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SWKHLAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Revenues:
Finance receivable interest income, including fees
Pharmaceutical development
Other
Total revenues
YoY growth-29.7%+4.5%-7.3%+4.2%
Costs and expenses:
Provision for (benefit from) credit losses
Loss on disposal of inventory——
Interest expense
Pharmaceutical manufacturing, research and development expense
Change in fair value of acquisition-related contingent consideration—
Depreciation and amortization expense
General and administrative expense
Income from operations
% of revenue9.9%61.3%46.1%68.6%
Other income (expense), net
Unrealized net gain on warrants
Net gain on exercise and cancellation of warrants—
Loss on sale of assets
Gain on sale of business——
Net loss on marketable investments
Net income (loss)
% of revenue-223.1%80.7%35.2%38.4%
Basic (in dollars per share)—
Diluted (in dollars per share)—